DAPAVILDA MET 10/100/500

About DAPAVILDA MET 10/100/500

Managing type 2 diabetes often requires more than a single medication to achieve optimal blood sugar control. DAPAVILDA MET 10/100/500 is a triple-combination oral anti-diabetic tablet that combines Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg. By targeting different mechanisms involved in glucose regulation, it helps improve glycemic control and supports long-term diabetes management.

What is DAPAVILDA MET 10/100/500?

DAPAVILDA MET 10/100/500 is a prescription medication developed for adults with type 2 diabetes mellitus. It combines three well-established anti-diabetic medicines into a single tablet, offering a convenient treatment option for individuals whose blood sugar levels are not adequately managed with one or two medications.

Composition

• Dapagliflozin 10 mg
• Vildagliptin SR 100 mg
• Metformin SR 500 mg

This combination provides a comprehensive approach to blood sugar management by addressing multiple pathways involved in glucose metabolism.

How Does DAPAVILDA MET 10/100/500 Work?

Each ingredient contributes to blood sugar control through a unique mechanism of action.

Dapagliflozin (SGLT2 Inhibitor)

• Helps remove excess glucose through urine.
• Lowers blood sugar levels independently of insulin.
• May provide additional benefits such as modest weight reduction and cardiovascular support in appropriate patients.

Vildagliptin SR (DPP-4 Inhibitor)

• Increases incretin hormone activity.
• Stimulates insulin release when blood sugar levels rise after meals.
• Reduces glucagon secretion, helping prevent excessive glucose production.

Metformin SR (Biguanide)

• Reduces glucose production by the liver.
• Improves the body's sensitivity to insulin.
• Slows the absorption of glucose from the digestive tract.

Together, these three medications work throughout the day to provide effective and sustained blood sugar control.

Uses of DAPAVILDA MET 10/100/500

This medication is commonly prescribed for:

Type 2 Diabetes Management

Helps control blood glucose levels in adults with type 2 diabetes.

Improved Glycemic Control

Suitable for patients who require combination therapy after inadequate response to single or dual anti-diabetic medications.

Reducing the Risk of Diabetes-Related Complications

Maintaining healthy blood sugar levels may help lower the risk of complications such as:

• Heart disease
• Kidney damage
• Nerve damage
• Vision-related problems

Key Benefits

DAPAVILDA MET 10/100/500 offers several advantages, including:

• Triple-action formula for comprehensive glucose control
• Sustained-release ingredients for longer-lasting effectiveness
• Helps lower HbA1c levels
• Supports weight management through dapagliflozin
• Lower risk of hypoglycemia when used as prescribed
• Convenient once-daily tablet, if recommended by the physician

Dosage and Administration

Recommended Dosage

The dosage should always be determined by a healthcare professional. In many cases, it is prescribed once daily.

How to Take

• Take the tablet with food to reduce stomach discomfort.
• Swallow it whole without crushing or chewing.
• Take it at the same time every day for consistent results.
• Follow your doctor's instructions carefully.

Who Can Benefit from DAPAVILDA MET 10/100/500?

This medication may be suitable for:

• Adults with type 2 diabetes mellitus.
• Patients whose blood sugar remains uncontrolled with metformin alone.
• Individuals requiring triple-drug therapy for improved glycemic management.

Possible Side Effects

Like any medication, DAPAVILDA MET 10/100/500 may cause side effects.

Common Side Effects

• Nausea
• Diarrhea
• Headache
• Urinary tract infections

Serious but Less Common Side Effects

• Lactic acidosis (rare, associated with metformin)
• Dehydration
• Pancreatitis
• Kidney-related complications

Seek immediate medical attention if you experience severe or persistent symptoms.

Precautions

Before taking DAPAVILDA MET 10/100/500, inform your healthcare provider if you:

• Have kidney or liver disease.
• Consume alcohol frequently.
• Are taking other prescription or over-the-counter medications.

Additional precautions include:

• Monitor blood sugar levels regularly.
• Stay adequately hydrated, especially while taking dapagliflozin.
• Attend routine medical follow-up appointments.

This Medicine May Not Be Suitable For

• People with type 1 diabetes.
• Patients with severe kidney impairment.
• Pregnant or breastfeeding women unless specifically advised by their doctor.

Drug Interactions

DAPAVILDA MET 10/100/500 may interact with certain medications, including:

• Diuretics, which may increase the risk of dehydration.
• Insulin or sulfonylureas, which may increase the risk of hypoglycemia.
• Certain antibiotics and other prescription medicines.

Always inform your healthcare provider about every medication and supplement you are taking.

Lifestyle Tips for Better Diabetes Control

Medication works best when combined with healthy lifestyle habits.

Eat a Balanced Diet

• Choose high-fiber, nutrient-rich foods.
• Limit refined carbohydrates and sugary beverages.
• Control portion sizes.

Stay Physically Active

Aim for at least 30 minutes of moderate exercise on most days to improve insulin sensitivity and overall health.

Monitor Your Health

• Check blood glucose levels as recommended.
• Get HbA1c tested every three to six months or as advised by your doctor.

Storage Instructions

• Store in a cool and dry place.
• Protect from direct sunlight and moisture.
• Keep out of the reach of children.

Why Choose DAPAVILDA MET 10/100/500?

DAPAVILDA MET 10/100/500 combines three clinically established anti-diabetic medications into a single tablet, simplifying treatment while addressing multiple aspects of blood sugar regulation. For patients requiring combination therapy, it offers an effective and convenient option to support long-term diabetes management when used alongside a healthy lifestyle and regular medical supervision.

Final Thoughts

Effective management of type 2 diabetes requires the right combination of medication, healthy eating, regular physical activity, and ongoing monitoring. DAPAVILDA MET 10/100/500 delivers a comprehensive triple-action approach with Dapagliflozin 10 mg, Vildagliptin SR 100 mg, and Metformin SR 500 mg, helping eligible patients achieve better glycemic control and reduce the risk of diabetes-related complications. Since treatment needs vary from person to person, always use this medication under the guidance of a qualified healthcare professional.